Avanos Medical To Acquire OrthogenRx

Avanos Medical entered into a definitive agreement to acquire OrthogenRx, developer of viscosupplementation therapies for the treatment of knee osteoarthritis (OA) pain, for a total consideration of USD $160 million. The purchase price comprises $130 million in cash at closing plus an additional $30 million in contingent cash consideration,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us